Viewing Study NCT02436993


Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2026-01-05 @ 10:45 PM
Study NCT ID: NCT02436993
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-14
First Post: 2015-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
Sponsor: University of California, Irvine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module